Ameritas Investment Partners’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,529
| Closed | -$20.6K | – | 3397 |
|
|
2025
Q1 | $20.6K | Hold |
3,529
| – | – | ﹤0.01% | 2542 |
|
|
2024
Q4 | $13.1K | Hold |
3,529
| – | – | ﹤0.01% | 2824 |
|
|
2024
Q3 | $19.7K | Hold |
3,529
| – | – | ﹤0.01% | 2666 |
|
|
2024
Q2 | $29.7K | Hold |
3,529
| – | – | ﹤0.01% | 2430 |
|
|
2024
Q1 | $51K | Hold |
3,529
| – | – | ﹤0.01% | 2138 |
|
|
2023
Q4 | $75.9K | Hold |
3,529
| – | – | ﹤0.01% | 1916 |
|
|
2023
Q3 | $67.8K | Buy |
3,529
+816
| +30% | +$17.4K | ﹤0.01% | 1912 |
|
|
2023
Q2 | $69K | Hold |
2,713
| – | – | ﹤0.01% | 1845 |
|
|
2023
Q1 | $98.1K | Hold |
2,713
| – | – | ﹤0.01% | 1549 |
|
|
2022
Q4 | $106K | Hold |
2,713
| – | – | ﹤0.01% | 1557 |
|
|
2022
Q3 | $126K | Hold |
2,713
| – | – | 0.01% | 1340 |
|
|
2022
Q2 | $118K | Hold |
2,713
| – | – | 0.01% | 1398 |
|
|
2022
Q1 | $196K | Hold |
2,713
| – | – | 0.01% | 1199 |
|
|
2021
Q4 | $220K | Hold |
2,713
| – | – | 0.01% | 1169 |
|
|
2021
Q3 | $316K | Hold |
2,713
| – | – | 0.01% | 932 |
|
|
2021
Q2 | $450K | Sell |
2,713
-53
| -2% | -$8.27K | 0.02% | 823 |
|
|
2021
Q1 | $386K | Sell |
2,766
-95
| -3% | -$15.5K | 0.01% | 862 |
|
|
2020
Q4 | $495K | Hold |
2,861
| – | – | 0.02% | 772 |
|
|
2020
Q3 | $399K | Sell |
2,861
-105
| -4% | -$14K | 0.02% | 777 |
|
|
2020
Q2 | $354K | Buy |
2,966
+293
| +11% | +$34.8K | 0.02% | 802 |
|
|
2020
Q1 | $267K | Buy |
2,673
+61
| +2% | +$7.34K | 0.02% | 820 |
|
|
2019
Q4 | $307K | Buy |
2,612
+180
| +7% | +$17.8K | 0.01% | 879 |
|
|
2019
Q3 | $209K | Hold |
2,432
| – | – | 0.01% | 1037 |
|
|
2019
Q2 | $158K | Hold |
2,432
| – | – | 0.01% | 1201 |
|
|
2019
Q1 | $152K | Hold |
2,432
| – | – | 0.01% | 1209 |
|
|
2018
Q4 | $95K | Hold |
2,432
| – | – | 0.01% | 1420 |
|
|
2018
Q3 | $139K | Hold |
2,432
| – | – | 0.01% | 1331 |
|
|
2018
Q2 | $194K | Hold |
2,432
| – | – | 0.01% | 1085 |
|
|
2018
Q1 | $211K | Hold |
2,432
| – | – | 0.01% | 1046 |
|
|
2017
Q4 | $168K | Hold |
2,432
| – | – | 0.01% | 1181 |
|
|
2017
Q3 | $209K | Hold |
2,432
| – | – | 0.01% | 1044 |
|
|
2017
Q2 | $181K | Buy |
2,432
+358
| +17% | +$28.7K | 0.01% | 1115 |
|
|
2017
Q1 | $194K | Buy |
+2,074
| New | +$188K | 0.01% | 1083 |
|
|
2016
Q4 | – | Sell |
-2,074
| Closed | -$217K | – | 1278 |
|
|
2016
Q3 | $217K | Buy |
+2,074
| New | +$187K | 0.01% | 978 |
|
Other funds holding NVRO
Ameritas Investment Partners's NVRO Position: Q2 2025 in Review
Ameritas Investment Partners sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 3,529 shares — an estimated $20.6K sold.
Ameritas Investment Partners first reported a position in NVRO in Q3 2016 and held it in 34 quarters. The position peaked at $495K in Q4 2020. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Ameritas Investment Partners reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Ameritas Investment Partners sold 3,529 NEVRO CORP. shares in Q2 2025, an estimated $20.6K.
- Ameritas Investment Partners first reported a position in NEVRO CORP. in Q3 2016 and held it in 34 quarters.
- Ameritas Investment Partners's NEVRO CORP. position peaked at $495K in Q4 2020.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.